Skip to main content
. Author manuscript; available in PMC: 2015 Apr 1.
Published in final edited form as: Nat Med. 2014 Sep 28;20(10):1193–1198. doi: 10.1038/nm.3686

Table 1.

Odds ratios for pancreatic cancer by prediagnostic plasma levels of branched chain amino acids

Modela Isoleucine Leucine Valine Total BCAAsc

Extreme Quintilesb Per S.D. Extreme Quintilesb Per S.D. Extreme Quintilesb Per S.D. Extreme Quintilesb Per S.D.
Base model 2.11 (1.40-3.18) 1.30 (1.15–1.48) 2.08 (1.38–3.13) 1.31 (1.14–1.50) 2.00 (1.37–2.92) 1.23 (1.09–1.39) 2.13 (1.43–3.15) 1.30 (1.14–1.48)
+ BMI and physical activity 2.05 (1.34–3.12) 1.29 (1.14–1.48) 2.01 (1.32–3.06) 1.29 (1.12–1.49) 1.94 (1.31–2.86) 1.21 (1.07–1.38) 2.06 (1.37–3.09) 1.28 (1.12–1.47)
+ BMI, physical activity, and reported diabetes at blood collection 2.00 (1.31–3.05) 1.28 (1.13–1.46) 1.97 (1.29–2.99) 1.28 (1.11–1.48) 1.90 (1.28–2.81) 1.20 (1.06–1.37) 2.01 (1.34–3.03) 1.27 (1.11–1.46)
+ BMI, physical activity, reported diabetes, HbA1c, plasma insulin, proinsulin and C–peptide 1.86 (1.13–3.03) 1.24 (1.06–1.45) 1.81 (1.11–2.96) 1.24 (1.04–1.47) 1.67 (1.06–2.63) 1.14 (0.99–1.33) 1.89 (1.17–3.06) 1.22 (1.04–1.44)
Exclude subjects with reported diabetes or HbA1c ≥6.5% at blood collection 2.12 (1.37–3.27) 1.33 (1.16–1.52) 2.16 (1.39–3.35) 1.32 (1.14–1.54) 1.91 (1.28–2.85) 1.23 (1.08–1.41) 2.19 (1.44–3.34) 1.31 (1.14–1.51)
Exclude subjects with reported diabetes or HbA1c ≥6.5% at blood collection and those with reported diabetes after blood collection 2.18 (1.39–3.43) 1.32 (1.15–1.53) 2.21 (1.40–3.49) 1.33 (1.13–1.55) 1.94 (1.27–2.96) 1.22 (1.07–1.40) 2.25 (1.45–3.49) 1.31 (1.13–1.52)
a

Odds ratio (95% confidence interval) from conditional logistic regression models conditioned on matching factors and adjusted for age at blood draw (years, continuous), fasting time (<4, 4–8, 8–12, ≥12 hours, missing) and race/ethnicity (White, Black, other, missing). Subsequent models also adjusted for indicated measure of energy balance, hyperglycemia or insulin resistance: body–mass index (kg/m2, continuous), physical activity (MET–hr/week, continuous), reported diabetes at blood collection (yes/no), Hemoglobin A1c (%, continuous), plasma insulin (μIU/ml, continuous), plasma proinsulin (pM, continuous), and plasma C–peptide (ng/ml, continuous).

b

Odds ratios (95% CI) for the comparison of the fifth quintile to the first quintile (referent) for the circulating branched chain amino acids

c

Sum of the concentrations of the three circulating branched chain amino acids, isoleucine, leucine and valine

Abbreviations: BCAAs, branched chain amino acids; BMI, body–mass index; CI, confidence interval; HbA1c, hemoglobin A1c; S.D., standard deviation